LOS ANGELES, Oct. 5, 2023 /PRNewswire/ — Tetrous, Inc., a regenerative medicine company, today announced that another patent (U.S. Patent Number 11,759,548) specifically related to the EnFix family of demineralized cortical bone fiber implants and their method of manufacture has been…
